Amastigote-positive and amastigote-negative chronic cutaneous leishmaniasis: Treatment results with a new topical herbal extract

Iranian Journal of Medical Sciences

Volumn 25, Issue 3-4, 2000, Pages 114-118

  Zerehsaz, F ^a   Beheshti, Sh ^a   Rezaian, Gh R ^a   Joubeh, S ^a  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Cutaneous; Herbal; Leishmaniasis; Medicine; Treatment

Indexed keywords

ANTIMONY; HERBACEOUS AGENT;

ADOLESCENT; ADULT; AGED; AMASTIGOTE; ARTICLE; CHILD; CHRONIC DISEASE; CLINICAL ARTICLE; CYTOKINE RELEASE; DRUG EFFECT; FEMALE; HUMAN; MALE; OUTCOMES RESEARCH; PROGNOSIS; SKIN LEISHMANIASIS; SMEAR; T LYMPHOCYTE ACTIVATION;

EID: 0034445129     PISSN: 02530716     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Estimation of population at risk of infection and number of cases of leishmaniasis
2. Twenty years of cutaneous leishmaniasis in Aleppo, Syria
3. Cutaneous leishmaniasis: An emerging epidemic focus of Leishmania tropica in north Morocco
4. Clinical picture of cutaneous leishmaniasis in Isfahan, Iran
5. Chronic destructive ulcerative lesions of the midface and nasal cavity due to leishmaniasis
6. Leishmaniasis
7. Studies on chronic (lupoid) leishmaniasis
8. A double-blind randomized clinical trial of a topical herbal extract "Z-HE" versus systemic meglumine antimonate for the treatment of cutaneous leishmaniasis in Iran
9. Recommendations for treating leishmaniasis with sodium stibogluconate (Pentostam) and review of pertinent clinical studies
10. Human leishmaniasis: Clinical, diagnostic, and chemotherapeutic developments in the last 10 years
11. Panceratitis induced by pentavalent antimonial agents during treatment of leishmaniasis